Grimes & Company »

Revolution Medicines shares owned by Grimes & Company

Quarter-by-quarter ownership of Revolution Medicines (RVMD) shares owned by Grimes & Company from 13F filings

Historical chart of Grimes & Company investment in Revolution Medicines

Tip: Access up to 7 years of quarterly data

All positions including Revolution Medicines held by Grimes & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revolution Medicines by Grimes & Company

Quarter filed Position value Share count Share price at filing
2026-06-30 $444k 2.4k 187.29

More positions owned by Grimes & Company

Vanguard Index Fds Small Cp Etf (VB)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p500 Etf (IVV)
Select Sector Spdr Tr St Str Techn Etf (XLK)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Spdr Series Trust St Term High Etf (SJNK)
Spdr Series Trust St Bloo High Etf (JNK)
John Hancock Exchange Traded Mltfctr Lrg Cap (JHML)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Select Sector Spdr Tr St Str Indl Etf (XLI)
Vanguard Index Fds Growth Etf (VUG)

View all positions for Grimes & Company

Top funds holding Revolution Medicines

Farallon Capital Management
BlackRock
Henderson Group
Baker Bros. Advisors
FMR
Vanguard Capital Management
Nextech Invest
Vanguard Portfolio Management
Paradigm Biocapital Advisors
Wellington Management Company
Adage Capital Partners GP
State Street Corporation
UBS Group
Geode Capital Management
Alphabet

View all funds holding Revolution Medicines